What is the Midterm Survivorship and Function After Hip Resurfacing?
Authors:
- 1 December 2010
- journal article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 468 (12) , 3221-3227
Abstract
Hip resurfacing arthroplasty is a common procedure that improves functional scores and has a reported survivorship between 95% and 98% at 5 years. However, most studies are reported from the pioneering rather than independent centers or have relatively small patient numbers or less than five years followup. Various factors have been implicated in early failure. Our purposes were to determine: (1) the midterm survival of the BHR; (2) the function in patients treated with hip resurfacing; and (3) whether age, gender, BMI, or size of components related to failure. We reviewed the first 302 patients (329 hips) on whom we performed resurfacing arthroplasty. We assessed the survivorship, change in functional hip scores (HHS, OHS, WOMAC, UCLA), and analyzed potential risk factors (age, gender, BMI, component size) for failure. The mean age at the time of surgery was 56.0 years (range, 28.2–75.5 years). The minimum followup was 5 years (mean, 6.6 years; range, 5–9.2 years). Kaplan-Meier analysis showed survival of 96.5% (95% CI, 94.7–98.4) at 9 years taking revision for any cause as the endpoint. All functional hip scores (HHS, OHS, WOMAC, UCLA) improved. Survivorship was higher in men compared with women. The component sizes and body mass index were smaller in the revised group compared with the nonrevised group. Medium-term survivorship and functional scores of hip resurfacing are comparable to those from the pioneering center. Hip resurfacing remains a good alternative to THA, particularly in the younger male population with relatively large femoral head sizes. Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.Keywords
This publication has 51 references indexed in Scilit:
- Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8+ T-cell lymphopeniaThe Journal of Bone and Joint Surgery. British volume, 2009
- Is Patient Selection Important for Hip Resurfacing?Clinical Orthopaedics and Related Research, 2009
- Birmingham hip resurfacing arthroplastyThe Journal of Bone and Joint Surgery. British volume, 2008
- Effect of bearing size on the long‐term wear, wear debris, and ion levels of large diameter metal‐on‐metal hip replacements—An in vitro studyJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2008
- The five-year results of the Birmingham Hip Resurfacing arthroplastyThe Journal of Bone and Joint Surgery. British volume, 2008
- Resurfacing THA for Patients Younger Than 50 YearsClinical Orthopaedics and Related Research, 2007
- Biomechanical reconstruction of the hipThe Journal of Bone and Joint Surgery. British volume, 2006
- Resurfacing Hip ArthroplastyClinical Orthopaedics and Related Research, 2005
- Birmingham hip resurfacing arthroplastyThe Journal of Bone and Joint Surgery. British volume, 2005
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958